Page 247 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 247

Polyarteritis Nodosa  221

[24] Porter BF, Frost P, Hubbard GB. Polyarteritis nodosa in a cynomolgus macaque
       (Macaca fascicularis). Vet. Pathol. 2003; 40:570-573.

[25] Colmegna I, Maldonado-Cocco JA. Polyarteritis nodosa revisited. Curr. Rheumatol.
       Rep. 2005; 7:288-296.

[26] Trepo C, Thivolet J. Antigene Australia, virus de l'hépatite et périartérite noueuse.
       Presse Méd. 1970;78(36):1575.

[27] Servant A, Bogard M, Delaugerre C, et al. GB virus C in systemic medium- and small-
       vessel necrotizing vasculitides. Br. J. Rheumatol. 1998; 37:1292-1294.

[28] Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet
       1992; 339:491.

[29] Leruez-Ville M, Lauge A, Morinet F, Guillevin L, Deny P. Polyarteritis nodosa and
       parvovirus B19. Lancet 1994; 344:263-264.

[30] Calabrese LH. Vasculitis and infection with the human immunodeficiency virus. Rheum
       Dis. Clin. North Am. 1991; 17:131-147.

[31] Gisselbrecht M, Cohen P, Lortholary O, et al. Human immunodeficiency virus-related
       vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann. Méd.
       Interne 1998; 149:398-405.

[32] Elkon KB, Hughes GR, Catovsky D, et al. Hairy-cell leukaemia with polyarteritis
       nodosa. Lancet 1979; 2:280-282.

[33] Hasler P, Kistler H, Gerber H. Vasculitides in hairy cell leukemia. Semin. Arthritis.
       Rheum. 1995; 25:134-142.

[34] Hutson TE, Hoffman GS. Temporal concurrence of vasculitis and cancer: a report of 12
       cases. Arthritis. Care Res. 2000; 13:417-423.

[35] Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am. J. Med.
       1967; 43:8-14.

[36] Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients
       with polyarteritis nodosa: a systematic retrospective study of patients diagnosed
       between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
       Arthritis Rheum 2010; 62:616-626.

[37] Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J. Neurol. 2005;
       252:633-641.

[38] Jamieson PW, Giuliani MJ, Martinez AJ. Necrotizing angiopathy presenting with
       multifocal conduction blocks. Neurology 1991; 41:442-444.

[39] Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitis.
       Muscle Nerve 1990; 13:102-105.

[40] Allan SG, Towla HM, Smith CC, et al. Painful brachial plexopathy: an unusual
       presentation of polyarteritis nodosa. Postgrad. Med. J. 1982; 58:311-313.

[41] Collins MP, Arnold WD, Kissel JT. The neuropathies of vasculitis. Neurol. Clin. 2013;
       31:557-595.

[42] Abgrall S, Mouthon L, Cohen P, et al. Localized neurological necrotizing vasculitides.
       Three cases with isolated mononeuritis multiplex. J. Rheumatol. 2001; 28:631-633.

[43] Moore PM, Calabrese LH. Neurologic manifestations of systemic vasculitides. Semin.
       Neurol. 1994; 14:300-306.

[44] Amarenco P, Amarenco G, Guillevin L, et a;/Roullet E, Sobann M, Baudrimont M, et
       al. Neuropathie vésicale dans les vascularites systémiques: 3 observations. Ann. Méd.
       Interne 1988; 139:183-185.

            Complimentary Contributor Copy
   242   243   244   245   246   247   248   249   250   251   252